{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-003205","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.318272+00:00","generated_at":"2026-05-21T04:48:57.291523+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Predictive Oncology Q1 loss $2.3M; revenue up to $110k; cash position improves to $3.1M","bullets":["Net loss from continuing ops $2.3M ($0.32 per share) vs $0.88 loss per share YoY.","Revenue $110,310 vs $4,858 YoY, driven by completion of tumor-specific 3D model.","Cash and equivalents $3.1M at March 31, 2025, up from $611k at Dec 31, 2024.","Sold Skyline Medical assets to DeRoyal; sharpens focus on AI/ML drug discovery.","Plans European launch of ChemoFx assay for ovarian/gynecological cancers; expanded US availability."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-003205","json":"https://secwatch.observer/filing/0001171843-25-003205.json","markdown":"https://secwatch.observer/filing/0001171843-25-003205.md","text":"https://secwatch.observer/filing/0001171843-25-003205.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325003205/0001171843-25-003205-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325003205/f8k_051425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:48:57.291523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}